▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #225 by analyst upside · 2026-06-27
CLNN
Clene Inc.
Consumer Defensive · Market Cap $77M · P/E 0x
ANALYST PRICE TARGET
+431.4%
implied upside to consensus target
Current Price $6.06
Consensus Target $32.2
Bull Target $50.0
Bear Target $20.0
Analysts Covering 5
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $3.25
52-Week High $13.5
YTD Return +5.0%
FUNDAMENTALS
Market Cap $77M
P/E Ratio (TTM) N/A
Forward P/E -3.4x
EPS (TTM) $-3.38
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $3.25
52-Week High $13.5
Current Price $6.06
Bear Target $20.0
Bull Target $50.0
● Now $6.06 ● Target $32.2
TRADING DATA
Avg Volume 503K
YTD Return +5.0%
Analyst Count 5
Consensus Buy
Upside to Target +431.4%
Last Updated 2026-06-27

ANALYST SUMMARY

Clene Inc. (CLNN) is currently trading at $6.06 with a Wall Street consensus price target of $32.2, implying potential upside of 431.4% over the next 12 months. 5 analysts currently cover CLNN, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $50.0, while the most cautious has a target of $20.0.

CLNN operates in the Consumer Defensive sector with a market capitalisation of $77M. The stock is up 5.0% year-to-date and is currently trading near the lower end of its 52-week range of $3.25 – $13.5.

SIMILAR STOCKS

Other Consumer Defensive stocks with comparable size and valuation.

VFF +160.1%
Village Farms International, In
$230M · P/E 8.2x · Buy
USNA +88.4%
USANA Health Sciences, Inc.
$382M · P/E 41.4x · Hold
MH +91.4%
McGraw Hill, Inc.
$2B · P/E 49.9x · Buy
DDL +75.3%
Dingdong (Cayman) Limited
$418M · P/E 17.4x · Buy
CELH +96.1%
Celsius Holdings, Inc.
$8B · P/E 69.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for CLNN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2026-05-04 31% win rate (48 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-05-04 32% win rate (25 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2026-03-13 Building track record
D. Boral Capital — Reiterated
Buy → Buy 2026-03-12 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2026-01-09 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2025-12-10 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2025-12-03 32% win rate (25 calls)
D. Boral Capital — Reiterated
Buy → Buy 2025-11-17 32% win rate (25 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →